Back to Top
Go Back
Journal Photo for JAMA Oncology
Peer reviewed only Open Access

JAMA Oncology (JAMA O)

Publisher : American Medical Association
Oncology Medicine Cancer Research
Claim Your Journal Get PRC Visit Website
e-ISSN 2374-2445
p-ISSN 2374-2437
Issue Frequency Monthly
Impact Factor 28.4
Est. Year 2015
Mobile 8002622350
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email jamaonc@jamanetwork.org

Journal Descriptions

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.

JAMA Oncology (JAMA O) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Oncology, Medicine, Cancer Research, Molecular Biology, Biochemistry , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2374-2437, E-ISSN: 2374-2445, Established: 2015, Impact Factor: 28.4
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of JAMA O

The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories
Mohammad Ali Moni September, 2023
Importance Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is cr...
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 201...
Mohammad Ali Moni December, 2021
Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and internati...
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Bert Vogelstein October, 2019
Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurren...